AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial Post author:Sam Post published:January 25, 2018 Post category:BioPharma Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace You Might Also Like FDA Approves Sanofi's Admelog, the First Follow-On Insulin to Control Sugar at Mealtime December 11, 2017 AstraZeneca Shows Off New Farxiga Data for Diabetes Patients with Chronic Kidney Disease March 19, 2018 BiologicTx Announces First Year International Transplantation Successes Utilizing Matchgrid May 1, 2017
FDA Approves Sanofi's Admelog, the First Follow-On Insulin to Control Sugar at Mealtime December 11, 2017
AstraZeneca Shows Off New Farxiga Data for Diabetes Patients with Chronic Kidney Disease March 19, 2018
BiologicTx Announces First Year International Transplantation Successes Utilizing Matchgrid May 1, 2017
